NEUARTIGES PROSTAGLANDINDERIVAT

European patent · EP3456710 · In force

Register entry

Publication number
EP3456710
Application number
EP17796123
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 9, 2017
Published
Mar 20, 2019
Granted
Jun 30, 2021
Protection ends at the latest
May 8, 2037
Next annual fee due
May 31, 2026
IPC classes
C07C 405/00 (2006.01)
A61K 31/5575 (2006.01)
A61P 9/08 (2006.01)
A61P 9/10 (2006.01)
A61P 9/12 (2006.01)
A61P 43/00 (2006.01)
Priority
JP 2016094196 09.05.2016
PCT application
PCT/JP2017/017489 09.05.2017
PCT publication
WO2017/195762 16.11.2017
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  2. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  3. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  4. May 11, 2022

    Change

    Published in Swissreg on 11.05.2022

  5. Aug 25, 2021

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 25.08.2021

  6. Jun 30, 2021

    Granted

    Published in Swissreg on 30.06.2021

Parties

Holder

AGC Inc.

AGC INC.

5-1, Marunouchi 1-chome,, Chiyoda-ku, Tokyo 1008405, JP

Nippon Zoki Pharmaceutical Co. Ltd

Nippon Zoki Pharmaceutical Co., Ltd.

2-3, Hiranomachi 4-chome, Chuo-ku Osaka-shi, Osaka 541-0046, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

TAGUCHI, Kazuki

Kato-shi Hyogo 673-1461, JP

YASUDA, Arata

Tokyo 100-8405, JP

SAWADA, Kazuyoshi

Kato-shi Hyogo 673-1461, JP

NANBA, Hiroyoshi

Kato-shi Hyogo 673-1461, JP

MATSUMURA, Yasushi

Tokyo 100-8405, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.